We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
David Klonoff

David C Klonoff MD, FACP, FRCP (Edin), Fellow AIMBE

Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services in San Mateo, CA; Clinical Professor of Medicine at UCSF, San Francisco, CA

David C. Klonoff, M.D., FACP, FRCP (Edin), Fellow AIMBE is an endocrinologist specializing in diabetes technology.  He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services in San Mateo, California and a Clinical Professor of Medicine at UCSF.  Dr. Klonoff received an FDA Director’s Special Citation Award in 2010 for outstanding contributions related to diabetes technology.  He has been cited as being in the top 1% of endocrinologists nationally by Castle Connolly Medical Ltd.  He was the lead investigator for the first randomized controlled multicenter trial of an outpatient artificial pancreas product.  Dr. Klonoff is a graduate of UC Berkeley, where he was elected to Phi Beta Kappa in his junior year, and UCSF Medical School, where he was elected to Alpha Omega Alpha in his junior year.  His postgraduate training included two years at UCLA Hospital and three years at UCSF Hospitals. 

Disclosures

Dr. Klonoff is a consultant for Insulet, Lifecare, Sanofi, and Voluntis and he has received research funding from Dexcom and Medtronic.